Putnam BioRevolution ETF Stock Price, News & Analysis

The ticker SYNB represents the Putnam BioRevolution ETF, an exchange-traded fund identified in public communications as Putnam BioRevolution ETF (SYNB). According to a Business Wire announcement issued by Franklin Templeton, the fund is scheduled to be liquidated and dissolved. The announcement explains that the liquidation is anticipated to occur on or about November 21, 2025, with related trading and order activity ceasing ahead of that date.

The Putnam BioRevolution ETF (SYNB) is associated with Franklin Templeton, which is described in the same announcement as a global investment management organization whose subsidiaries operate under the Franklin Templeton name. The communication notes that Franklin Templeton’s mission is to help clients achieve better outcomes through investment management expertise, wealth management and technology solutions, and that it offers capabilities in equity, fixed income, alternatives and multi-asset solutions through its specialist investment managers.

The liquidation plan for SYNB includes several key steps described in the announcement. Effective as of the close of business on October 24, 2025, the fund will no longer accept orders for the purchase of creation units. Effective as of the close of business on November 13, 2025, the fund will no longer accept redemption orders. Trading for the fund on NYSE Arca, Inc. (NYSE Arca) is expected to be suspended prior to market open on November 14, 2025.

Following the suspension of trading and the cessation of purchases and redemptions, the announcement states that, as soon as reasonably practicable on or after the liquidation date, the fund will liquidate its remaining assets after payment or provision for charges, taxes, expenses and liabilities. After any dividend determinations, the fund intends to distribute cash pro rata to all remaining shareholders as of the liquidation date who have not previously redeemed all of their shares. The announcement notes that proceeds of the liquidation are currently scheduled to be sent to shareholders on or about November 21, 2025, and that shareholders should consult their tax advisors about the tax implications of the liquidation.

Franklin Resources, Inc., which is identified with the NYSE ticker BEN in the same announcement, is described as a California-based company with subsidiaries operating as Franklin Templeton and serving clients in over 150 countries. The announcement highlights that Franklin Templeton brings extensive capabilities in equity, fixed income, alternatives and multi-asset solutions, and that it has many investment professionals and offices in major financial markets around the world. These details provide context for the asset management group responsible for the Putnam BioRevolution ETF (SYNB).

Because the fund is in the process of being liquidated and dissolved, SYNB should be understood in a historical and transitional context. The Business Wire announcement outlines a defined timeline for the end of trading, the halt of creation and redemption activity, and the distribution of liquidation proceeds to shareholders. Investors and observers reviewing SYNB as a symbol can use this information to understand that the fund is not being positioned for ongoing operation, but instead is moving through a planned wind-down process as described in the Franklin Templeton communication.